BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1711544)

  • 1. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.
    Nagayama Y; Wadsworth HL; Russo D; Chazenbalk GD; Rapoport B
    J Clin Invest; 1991 Jul; 88(1):336-40. PubMed ID: 1711544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30.
    Nagayama Y; Rapoport B
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1425-30. PubMed ID: 1361193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
    Tahara K; Yamamoto K; Tamura Y; Yoshida S
    Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure.
    Akamizu T; Inoue D; Kosugi S; Kohn LD; Mori T
    Thyroid; 1994; 4(1):43-8. PubMed ID: 8054860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective binding of thyrotropin receptor autoantibodies to recombinant extracellular domain of thyrotropin/lutropin-chorionic gonadotropin receptor chimeric proteins.
    Seetharamaiah GS; Zhuang J; Huang J; Patibandla SA; Kaithamana S; Tahara K; Kohn LD; Prabhakar BS
    Thyroid; 1999 Sep; 9(9):879-86. PubMed ID: 10524566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding.
    Hidaka A; Ban T; Panesar NS; Minegishi T; Kohn LD; Tahara K
    Thyroid; 1994; 4(4):447-57. PubMed ID: 7711510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.
    Nagayama Y; Wadsworth HL; Chazenbalk GD; Russo D; Seto P; Rapoport B
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):902-5. PubMed ID: 1992482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
    Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
    Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction.
    Akamizu T; Inoue D; Kosugi S; Ban T; Kohn LD; Imura H; Mori T
    Endocr J; 1993 Jun; 40(3):363-72. PubMed ID: 7920890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.
    Tahara K; Ban T; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1991 Aug; 179(1):70-7. PubMed ID: 1883391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
    Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding.
    Nagayama Y; Russo D; Chazenbalk GD; Wadsworth HL; Rapoport B
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1150-6. PubMed ID: 2176485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.